209 related articles for article (PubMed ID: 29704308)
41. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.
Pierpont ME; Magoulas PL; Adi S; Kavamura MI; Neri G; Noonan J; Pierpont EI; Reinker K; Roberts AE; Shankar S; Sullivan J; Wolford M; Conger B; Santa Cruz M; Rauen KA
Pediatrics; 2014 Oct; 134(4):e1149-62. PubMed ID: 25180280
[TBL] [Abstract][Full Text] [Related]
42. Epilepsy in RAS/MAPK syndrome: two cases of cardio-facio-cutaneous syndrome with epileptic encephalopathy and a literature review.
Adachi M; Abe Y; Aoki Y; Matsubara Y
Seizure; 2012 Jan; 21(1):55-60. PubMed ID: 21871821
[TBL] [Abstract][Full Text] [Related]
43. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
[TBL] [Abstract][Full Text] [Related]
44. Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.
Makita Y; Narumi Y; Yoshida M; Niihori T; Kure S; Fujieda K; Matsubara Y; Aoki Y
J Pediatr Hematol Oncol; 2007 May; 29(5):287-90. PubMed ID: 17483702
[TBL] [Abstract][Full Text] [Related]
45. A transient myelodysplastic/myeloproliferative neoplasm in a patient with cardio-facio-cutaneous syndrome and a germline BRAF mutation.
Sekiguchi K; Maeda T; Suenobu S; Kunisaki N; Shimizu M; Kiyota K; Handa YS; Akiyoshi K; Korematsu S; Aoki Y; Matsubara Y; Izumi T
Am J Med Genet A; 2013 Oct; 161A(10):2600-3. PubMed ID: 23950000
[TBL] [Abstract][Full Text] [Related]
46. The perinatal presentation of cardiofaciocutaneous syndrome.
Wong Ramsey KN; Loichinger MH; Slavin TP; Kuo S; Seaver LH
Am J Med Genet A; 2014 Aug; 164A(8):2036-42. PubMed ID: 24719372
[TBL] [Abstract][Full Text] [Related]
47. Neurological complications of cardio-facio-cutaneous syndrome.
Yoon G; Rosenberg J; Blaser S; Rauen KA
Dev Med Child Neurol; 2007 Dec; 49(12):894-9. PubMed ID: 18039235
[TBL] [Abstract][Full Text] [Related]
48. Antenatal diagnosis of cardio-facio-cutaneous syndrome: Prenatal characteristics and contribution of fetal facial dysmorphic signs in utero. About a case and review of literature.
Biard JM; Steenhaut P; Bernard P; Race V; Sznajer Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():232-241. PubMed ID: 31336229
[TBL] [Abstract][Full Text] [Related]
49. Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.
Narumi Y; Aoki Y; Niihori T; Neri G; Cavé H; Verloes A; Nava C; Kavamura MI; Okamoto N; Kurosawa K; Hennekam RC; Wilson LC; Gillessen-Kaesbach G; Wieczorek D; Lapunzina P; Ohashi H; Makita Y; Kondo I; Tsuchiya S; Ito E; Sameshima K; Kato K; Kure S; Matsubara Y
Am J Med Genet A; 2007 Apr; 143A(8):799-807. PubMed ID: 17366577
[TBL] [Abstract][Full Text] [Related]
50. Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: cardiofaciocutaneous syndrome and Noonan syndrome.
Pierpont EI; Pierpont ME; Mendelsohn NJ; Roberts AE; Tworog-Dube E; Rauen KA; Seidenberg MS
Am J Med Genet A; 2010 Mar; 152A(3):591-600. PubMed ID: 20186801
[TBL] [Abstract][Full Text] [Related]
51. Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study.
Pierpont EI; Kenney-Jung DL; Shanley R; Zatkalik AL; Whitmarsh AE; Kroening SJ; Roberts AE; Zenker M
Genet Med; 2022 Jul; 24(7):1556-1566. PubMed ID: 35524774
[TBL] [Abstract][Full Text] [Related]
52. Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans.
Gualtieri A; Kyprianou N; Gregory LC; Vignola ML; Nicholson JG; Tan R; Inoue SI; Scagliotti V; Casado P; Blackburn J; Abollo-Jimenez F; Marinelli E; Besser REJ; Högler W; Karen Temple I; Davies JH; Gagunashvili A; Robinson ICAF; Camper SA; Davis SW; Cutillas PR; Gevers EF; Aoki Y; Dattani MT; Gaston-Massuet C
Nat Commun; 2021 Apr; 12(1):2028. PubMed ID: 33795686
[TBL] [Abstract][Full Text] [Related]
53. Patient-derived iPSCs show premature neural differentiation and neuron type-specific phenotypes relevant to neurodevelopment.
Yeh E; Dao DQ; Wu ZY; Kandalam SM; Camacho FM; Tom C; Zhang W; Krencik R; Rauen KA; Ullian EM; Weiss LA
Mol Psychiatry; 2018 Aug; 23(8):1687-1698. PubMed ID: 29158583
[TBL] [Abstract][Full Text] [Related]
54. Cardio
Chen B; Chen S; Xiong J; Yin F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 46(4):432-437. PubMed ID: 33967092
[TBL] [Abstract][Full Text] [Related]
55. Eyelid nystagmus in a child with cardiofaciocutaneous syndrome associated with BRAF mutation.
Wong BM; Matsumoto JH; Pineles SL
J AAPOS; 2022 Apr; 26(2):95-97. PubMed ID: 35149204
[TBL] [Abstract][Full Text] [Related]
56. The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic-Therapeutic Implications.
Scorrano G; David E; Calì E; Chimenz R; La Bella S; Di Ludovico A; Di Rosa G; Gitto E; Mankad K; Nardello R; Mangano GD; Leoni C; Ceravolo G
Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136934
[TBL] [Abstract][Full Text] [Related]
57. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
[TBL] [Abstract][Full Text] [Related]
58. Behavioral functioning in cardiofaciocutaneous syndrome: Risk factors and impact on parenting experience.
Pierpont EI; Wolford M
Am J Med Genet A; 2016 Aug; 170(8):1974-88. PubMed ID: 27149079
[TBL] [Abstract][Full Text] [Related]
59. Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish.
Anastasaki C; Rauen KA; Patton EE
Dis Model Mech; 2012 Jul; 5(4):546-52. PubMed ID: 22301711
[TBL] [Abstract][Full Text] [Related]
60. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.
Rauen KA; Banerjee A; Bishop WR; Lauchle JO; McCormick F; McMahon M; Melese T; Munster PN; Nadaf S; Packer RJ; Sebolt-Leopold J; Viskochil DH
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):136-46. PubMed ID: 21495172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
